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ABSTRACT
Objective: Hypertension (HTN) expends a consequential public health concern on cardiovascular health status and health-care systems in India. The 
effectuation of the pharmaceutical care program in the health care is an extremely important need to achieve the optimum therapeutic effect. The 
objective of the study was to assess the impact of pharmacist intervention on patient’s blood pressure (BP) level, quality of life (QOL), and knowledge, 
attitude, and practice (KAP) of hypertensive patients.
Methods: A randomized controlled pilot study was carried out for 6 months. The hypertensive patients were randomized into control and intervention 
group based on age, and both the groups were interviewed using KAP and WHO QOL-BREF questionnaires, screened BP, respectively, at baseline and 
each follow-up after post counseling section to the intervention group. The effect of pharmacist intervention on QOL and KAP among control and 
intervention was statistically analyzed by paired t-test using SPSS version 16.
Results: The total sample studied was 60, of which 20 (33.33%) were males and 40 (66.67%) were females. In our study, the QOL score for each 
domain of both intervention and control groups were almost poor (p˃0.05) at baseline and for the intervention group, a highly significant improvement 
(p<0.001) was observed for all domains in final follow-up. KAP score of intervention group also showed a significant improvement (p<0.001) from 
baseline to final follow-up. In this study, intervention group showed a significant mean reduction of systolic BP from baseline 150.13±25.670 to final 
follow-up 145.33±12.914.
Conclusion: The results of the study showed a significant improvement in the patient’s KAP toward different aspects of HTN and QOL following 
pharmacist mediated counseling. Involvement of pharmacy practitioners in the management of HTN significantly improves QOL and KAPs.
Keywords: Hypertension, Quality of life, Knowledge, Attitude and practice, Pharmacist intervention, Patient counseling.
INTRODUCTION
High blood pressure (BP) is the leading cause of cardiovascular 
disease (CVD) and deaths around the world. It is estimated that elevated 
BP alone causes about 50% of CVD worldwide, and it is associated 
with at least 7.6 million deaths per year worldwide (13.5% of all 
deaths), making it the prominent risk factor for CVD [1]. In 2000, over 
972 million adult populations were predicted to have hypertension 
(HTN) and this quantity is anticipated to rise to 1.56 billion by the year 
2025 [2].
HTN expends a consequential public health concern on cardiovascular 
health status and health-care systems in India [3]. HTN is directly 
responsible for 57% of all stroke deaths and 24% of all coronary 
heart disease deaths in India [4]. From an analysis of multinational 
data on the global burden of HTN, 20.6% of Indian men and 20.9% of 
Indian women were suffering from HTN in 2005. The rates of HTN in 
percentage are forecast to go up to 22.9 and 23.6 for Indian men and 
women, respectively, by 2025 [1].
Recent surveys reveal continuing deficiencies in the awareness, 
treatment, and management of HTN. In many incidents, failure to 
accomplish BP goals may be determinable to the poorness of patients’ 
knowledge, perception, attitudes, and lifestyle practices [5]. In HTN, 
knowledge and attitudes of the patients can affect compliance, the BP 
control, morbidity, and mortality of the patients. Comorbidity associated 
with HTN may influence how person with HTN rate with their quality 
of life (QOL). Poor management of HTN leads to several complications 
and end organ damage that ultimately impairs the health-related QOL 
in the individuals [6]. Reliable knowledge about drift in BP is needed 
to understand its dietary, lifestyle, and pharmacological determinants 
within populations. The effectuation of the pharmaceutical care 
program in the health care is an extremely important need to accomplish 
the optimum therapeutic effect that improves patient’s QOL [7].
METHODS
The randomized controlled pilot study was carried out for 6 months in 
the rural areas of Komarapalayam, Tamil Nadu. A total of 60 patients 
were enrolled as subjects based on inclusion criteria (patients 
diagnosed with HTN of either sex, aged between 20 and 80 years 
with or without comorbidities) and exclusion criteria (patients with 
cognitive and psychiatric problems, pregnant and lactating women, 
pediatric population).
The study received approval from the Institutional Ethical Committee 
about the work to be carried. After obtaining informed consent from 
the patient, the demographic data (age, gender, social status, economic 
status, and diagnosis and drug usage) were collected using a suitable 
data collection form. Total 60 hypertensive patients were randomized 
into control (n=30) and intervention (n=30) group based on age. The 
study design was divided into the baseline, 1st visit and 2nd visit with a 
difference of 1 month for each visit. The baseline demography data, BP 
levels, knowledge, attitude, and practice (KAP), and QOL scores were 
obtained from control and intervention group. After incorporation of 
baseline data, the patient counseling was given only for intervention 
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group by orally, visually, and by providing patient information leaflets 
(PIL) between periods of each follow-up. The BP level, scores of KAP and 
QOL were obtained for both intervention (after each post counseling 
session) and control groups at the end of 1st and 2nd visit.
Content of counseling was designed as follows
Before 1st follow-up
• Audiovisuals session about general awareness of HTN (causes, 
diagnosis, normal values of BP, complications) in first 2 weeks of 
1st month
• Audiovisual session and oral counseling on lifestyle modifications 
(Emphasized information about salt intake moderation; adopting 
a healthy eating plan in line with dietary approaches to stop HTN 
diet; weight reduction; physical exercise; cessation of risk factors 
(smoking and alcohol intake); prevention of complication) in 3rd and 
4th weeks of 1st month.
Before 2nd follow-up
• Drug compliance (importance of drugs on disease, how to take, and 
common side effects) in first 2 weeks of 2nd month
• PIL about the disease, dietary plan, management of smoking, weight 
reduction in 3rd and 4th weeks of the 2nd month.
Statistical analysis
The gathered data were statistically analyzed by computer software 
package (SPSS), version 16 based on paired t-test. An alpha error level 
of p<0.001 showed a highly significant improvement.
RESULTS
The total sample studied was 60, of which 20 (33.33%) were males and 
40 (66.67%) were females (Table 1). Age-wise distribution (Table 1) 
shown that most of the hypertensive patients were more in the age 
range of 51-60 (28.33%) and 61-70 (25%). There was a high prevalence 
of HTN in illiterate group (45%) than primary (20%), secondary 
(28.33%), and graduate (6.67%) (Table 1).
The percentage of body mass index (BMI) of hypertensive patients 
(Table 2) in control group was distributed as underweight (0%), normal 
weight (33.33%), overweight (40%), and obese (26.67%) and the 
percentage of BMI of hypertensive patients (Table 2) in intervention group 
as underweight (3.33%), normal weight (43.33%), overweight (33.33%), 
and obese (20%). Patients with lack of physical activity were 80% and 
83.37% in control and intervention group, respectively (Table 2).
The stages of HTN (according to JNC7) (Table 2) in control group as pre-
HTN (16.67%), stage 1 HTN (66.66%), and stage 2 HTN (16.67%) and 
the stages of HTN (according to JNC7) (Table 2) in intervention group 
as pre-HTN (16.67%), stage 1 HTN (53.33%), and stage 2 HTN (30%).
Comparison of QOL scores in both intervention and control groups
Domain 1 (physical health)
Scores of intervention group from baseline to second follow-up (Table 3) 
revealed that mean increases in physical health from 13.07±1.172 to 
16.47±1.502 which was statistically significant (p<0.001). Whereas in 
control group, the score from baseline to second follow-up (13.03±1.189 
to 13.00±1.083) was statistically nonsignificant (p˃0.05).
Domain 2 (psychological)
Scores of intervention group from baseline to second follow-up 
(Table 3) showed that mean increases in psychological health from 
12.47±1.252 to 15.17±0.874 which was clinically significant (p<0.001). 
Whereas in control group, the score from baseline to second follow-up 
(12.03±1.474 to 11.67±1.348) was nonsignificant (p˃0.05).
Domain 3 (social)
Scores of intervention group from baseline to second follow-up (Table 3) 
showed that mean increases in a social relationship from 13.33±1.807 to 
15.93±2.273 which was clinically significant (p<0.001). Whereas in the 
control group the score, from baseline to second follow-up (13.07±1.856 
to 12.80±2.592) was statistically nonsignificant (p˃0.05).
Domain 4 (environment)
Scores of intervention group from baseline to second follow-up 
(Table 3) revealed that mean increases in environment health from 
12.93±1.311 to 17.23±1.357 which was clinically significant (p<0.001). 
Whereas in control group, the score from baseline to second follow-up 
(12.60±1.734 to 12.93±1.799) was statistically nonsignificant (p˃0.05).
In this study, a gradual improvement in the QOL scores was observed 
in the intervention group patients, whereas, in control group, patients 
score was not significant (Table 3).
Table 1: Demographic profile of participants





21-30 years 1 (1.67)
31-40 years 3 (5)
41-50 years 14 (23.33)
51-60 years 17 (28.33)
61-70 years 15 (25)






Table 2: Demographic characteristics of control and intervention group
Parameters Control (n=30) (%) Intervention (n=30) (%)
BMI (kg/m2)
Under weight (<18.49) 0 (0) 1 (3.33)
Normal weight (18.50−24.99) 10 (33.33) 13 (43.33)
Overweight (25.00−29.99) 12 (40) 10 (33.33)
Obese (≥30.00) 8 (26.67) 6 (20)
Physical activity
Exercise 6 (20) 5 (16.66)
Lack of exercise 24 (80) 25 (83.37)
JNC 7 classification of HTN
Pre-HTN (SBP = 120−139 or DBP=80−89) 5 (16.67) 5 (16.67)
Stage 1 HTN (SB=140−159 or DBP=90−99) 20 (66.66) 16 (53.33)
Stage 2 HTN (SBP=≥160 or DBP=≥100) 5 (16.67) 9 (30)
BMI: Body mass index, HTN: Hypertension, DBP: Diastolic blood pressure, SBP: Systolic blood pressure
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Comparison of KAP score of hypertensive patients in both control 
and intervention groups
In this study, at baseline both the intervention and control groups, 
patients showed poor KAP toward HTN (Table 4).
Knowledge
Scores of intervention group from baseline to second follow-
up (Table 4) revealed that mean increases in knowledge from 
1.87±1.358 to 5.83±0.461 which was clinically significant (p<0.001). 
Whereas in control group, the score from baseline to second follow-up 
(2.00±1.083 to 2.47±1.224) was statistically nonsignificant (p˃0.05).
Attitude
Scores of intervention group from baseline to second follow-up (Table 4) 
showed that mean increases in attitude from 4.37±1.299 to 5.97±0.183 
which was clinically significant (p<0.001). Whereas in control group, 
the score from baseline to second follow-up (4.37±1.474 to 4.40±1.567) 
was statistically nonsignificant (p˃0.05).
Practice
Scores of intervention group from baseline to second follow-up (Table 4) 
showed that mean increases in practice from 5.23±1.794 to 7.40±1.653 
which was clinically significant (p<0.001). Whereas in control group, 
the score from baseline to second follow-up (5.07±1.552 to 5.13±1.502) 
was statistically nonsignificant (p˃0.05).
The changes in BP measurements of the intervention and control groups 
before and after patient counseling were described in (Table 5). In this 
study, the intervention group showed a significant mean reduction 
of systolic BP from baseline to 2nd follow-up (150.13±25.670 to 
145.33±12.914).
Table 3: QOL score for intervention and control group in HTN patients
QOL Mean±SD t‑value p‑value Significance level
Intervention Control
Domain 1 (physical health)
Baseline 13.07±1.172 13.03±1.189 0.166 ˃0.05 Non-significant
1st follow-up 14.77±1.431 13.03±1.098 5.794 ˂0.001 Highly significant
2nd follow-up 16.47±1.502 13.00±1.083 11.77 ˂0.001 Highly significant
Domain 2 (psychological)
Baseline 12.47±1.252 12.03±1.474 1.282 ˃0.05 Non-significant
1st follow-up 13.83±1.464 11.93±1.413 0.573 ˂0.001 Highly significant
2nd follow-up 15.17±0.874 11.67±1.348 11.727 ˂0.001 Highly significant
Domain 3 (social relationship)
Baseline 13.33±1.807 13.07±1.856 0.718 ˃0.05 Non-significant
1st follow-up 13.73±2.180 12.83±2.479 1.568 ˃0.05 Non-significant
2nd follow-up 15.93±2.273 12.80±2.592 5.123 ˂0.001 Highly significant
Domain 4 (environment)
Baseline 12.93±1.311 12.60±1.734 0.874 ˃0.05 Non-significant
1st follow-up 15.13±1.570 12.97±1.938 5.360 ˂0.001 Highly significant
2nd follow-up 17.23±1.357 12.93±1.799 12.302 ˂0.001 Highly significant
p>0.5; non-significant, p<0.01; significant, p<0.001; highly significant. HTN: Hypertension, QOL: Quality of life, SD: Standard deviation
Table 4: KAP score for the intervention and control group in HTN patients
KAP Mean±SD t‑value p‑value Significance level
Intervention Control
Knowledge
Baseline 1.87±1.358 2.00±1.083 −0.486 ˃0.05 Non-significant
1st follow-up 5.07±0.583 2.37±1.351 10.807 <0.001 Highly significant
2nd follow-up 5.83±0.461 2.47±1.224 14.809 <0.001 Highly significant
Attitude
Baseline 4.37±1.299 4.37±1.474 0.000 ˃0.05 Non-significant
1st follow-up 5.90±0.403 4.37±1.497 5.350 <0.001 Highly significant
2nd follow-up 5.97±0.183 4.40±1.567 5.805 <0.001 Highly significant
Practice
Baseline 5.23±1.794 5.07±1.552 0.407 ˃0.05 Non-significant
1st follow-up 6.10±1.626 5.13±1.548 2.436 <0.01 Significant
2nd follow-up 7.40±1.653 5.13±1.502 5.959 <0.001 Highly significant
p>0.5; non-significant, p<0.01; significant, p<0.001; highly significant. KAP: Knowledge, attitude and practice, HTN: Hypertension, SD: Standard deviation
Table 5: Mean score of systolic and diastolic blood pressure of the intervention and control groups before and after counselling
Blood pressure Mean±SD
Intervention Control
Baseline After follow‑up 2 Baseline After follow‑up 2
SBP 150.13±25.670 145.33±12.914 146.97±13.75 150.50±11.985
DBP 85.83±12.109 86.67±4.011 84.13±7.678 87.77±4.272
SBP: Systolic blood pressure, DBP: Diastolic blood pressure, SD: Standard deviation
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DISCUSSION
The randomized controlled study focuses on the impact of pharmacist-
provided patient counseling and education on patient’s KAP and QOL 
among hypertensive patients. In this study, female hypertensive population 
was higher than males. The postmenopausal women are at greater risk of 
cardiovascular problems in India as well as globally, and this risk increases 
with age [8]. Estrogen receptor-dependent mechanisms regulating 
vascular tone include endothelium-independent vasodilatation, increases 
in nitrous oxide bioavailability, inhibition of growth of vascular smooth 
muscle cell, inhibition of the vascular renin-angiotensin-aldosterone 
system and endothelin system, and inhibition of the sympathetic nervous 
system. The physiological withdrawal of estrogen among postmenopausal 
women generates changes in their fat distribution pattern and BP [9]. 
Another study also has reported that prevalence of HTN among women 
increased with higher BMI, waist-height ratio, waist-hip ratio, menopause 
status, unemployment status, nuclear family set up, low educational 
status, and higher socioeconomic status [10].
The proportions of HTN, as well as the mean systolic and diastolic BP, 
were found to increase steadily with an increase in age. Changes of 
BP with age might be due to the changes in the vascular system [11]. 
Peculiar features of large and small arteries that occur with aging 
include endothelial dysfunction, vascular remodeling, inflammation, 
calcification, and increased stiffness [12]. Another study also showed 
a significant positive correlation of systolic as well as diastolic BP with 
age [13].
HTN prevalence decreased with higher education and high prevalence 
of HTN in the low educated group might be the result of low tendency 
of these people to pay attention to their health and not being informed 
enough about the things to do or not to do for HTN. Furthermore, low 
education usually accompanies low income, which causes a further 
barrier to getting the medication [14].
Physical inactivity and BMI were correlated with higher levels of 
BP [15]. The mechanism responsible for obesity-linked variations in the 
pressure-natriuresis curve like enhanced sympathetic tone, activation 
of the renin-angiotensin system, hyperinsulinemia, structural changes 
in the kidney, and elaboration of adipokines (hormones produced in 
fat itself) such as leptin [16]. Reduction on the tensional levels is due 
to the expansion of the plasmatic volume, in the improvement of the 
endothelial function and in the action improvement and increase on 
the insulin sensitivity in the skeletal musculature. The exercise is also 
able to promote the angiogenesis by increasing the blood flow into the 
skeletal muscles and the cardiac muscle. Significant improvement in BP 
occurred only with aerobic exercise [17]. The prevalence of stage 1 and 
stage 2 HTN was higher in the older subjects. Changes of BP with age 
might be due to the changes in the vascular system [11,18].
In this study, a gradual improvement in the QOL scores was observed 
in the intervention group patients, whereas, in control group, patients 
score was not significant. Another study also showed that there was a 
positive influence of pharmacist mediated counseling on QOL [19].
In both the groups, patients had poor KAP at baseline. KAP Scores of 
the hypertensive patients were poor at baseline due to lack of patient 
education about disease, drugs, and lifestyle modification which reduces 
self-management skills and further complications. There was need for 
more enlightenment and proper education of hypertensive patients 
about the disease and other relevant issues relating to the disease [20].
In this study, the intervention group showed a significant mean 
reduction of systolic BP after pharmacist mediated counseling. The 
previous study also showed similarities with these results [21].
CONCLUSION
The results of the study showed a significant enhancement in the QOL 
of patients following pharmacist mediated counseling since there 
was an improvement in QOL score from baseline to final follow-up. 
The applied health education was an effective tool that implicated a 
significant change in patient’s KAP toward different aspects of HTN. 
HTN affects the QOL of patients and suggests that education has a major 
role in improving health-care outcomes. Involvement of pharmacy 
practitioners in the management of HTN significantly improves overall 
QOL and KAP.
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